Literature DB >> 28653289

Histamine H4 receptor signalling in tongue cancer and its potential role in oral carcinogenesis - a short report.

Abdelhakim Salem1,2, Rabeia Almahmoudi3, Dyah Listyarifah4,3,5, Maria Siponen6,7, Katariina Maaninka8, Ahmed Al-Samadi3, Tuula Salo3,9,10, Kari K Eklund4,11.   

Abstract

PURPOSE: Recent reports indicate that histamine and its novel, high-affinity histamine H4 receptor (H4R) play a role in carcinogenesis, and thus H4R signalling has become a focus of increasing interest in the pathogenesis of many cancers. The roles of H4R in oral epithelial dysplasia (OED) and oral tongue squamous cell carcinoma (OTSCC) are unknown. The purpose of this study was to assess H4R expression in OTSCC patients and in OTSCC-derived cell lines.
METHODS: Biopsies taken from OED, OTSCC and healthy oral mucosa were studied by immunostaining. Primary human oral keratinocytes (HOKs) and two OTSCC-derived cell lines (HSC-3 and SCC-25) were used for the in vitro studies. Quantitative real-time PCR was used to measure oncogene expression in the stimulated HOKs.
RESULTS: We found that H4R-immunoreactivity was significantly reduced in the OED and OTSCC samples, especially in the samples with higher histopathological grades and noticeably increased mast cell counts. The presence of H4R in HSC-3 cells had clearly waned, in contrast to the HOKs. Gene expression data indicated that histamine-relevant inflammatory and environmental elements may participate in the regulation of oncogenes.
CONCLUSIONS: Our results suggest an association between H4R and oral carcinogenesis. Furthermore, our findings raise a potential implication of histamine-mediated factors in the regulation of oncogenes, possibly via mast cells, as crucial components of the tumor microenvironment. The identification of new elements that govern oral cancer development is highly relevant for the development of novel therapeutic approaches in OTSCC.

Entities:  

Keywords:  Histamine; Histamine H4 receptor; Mast cells; Oral cancer; Oral epithelial dysplasia; Oral tongue squamous cell carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28653289     DOI: 10.1007/s13402-017-0336-6

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  33 in total

1.  Recent advances in head and neck cancer.

Authors:  Robert I Haddad; Dong M Shin
Journal:  N Engl J Med       Date:  2008-09-11       Impact factor: 91.245

2.  Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation.

Authors:  Zoya B Kurago; Aroonwan Lam-ubol; Anton Stetsenko; Chris De La Mater; Yiyi Chen; Deborah V Dawson
Journal:  Head Neck Pathol       Date:  2008-03

3.  Prognostic factors in the surgical treatment of patients with oral carcinoma.

Authors:  Rajan S Patel; Jonathan R Clark; Richard Dirven; Rebecca Wyten; Kan Gao; Christopher J O'Brien
Journal:  ANZ J Surg       Date:  2009 Jan-Feb       Impact factor: 1.872

4.  Histamine-cytokine connection in immunity and hematopoiesis.

Authors:  Michel Dy; Elke Schneider
Journal:  Cytokine Growth Factor Rev       Date:  2004-10       Impact factor: 7.638

5.  Histamine metabolism and transport are deranged in human keratinocytes in oral lichen planus.

Authors:  A Salem; S Rozov; A Al-Samadi; V Stegajev; D Listyarifah; V-P Kouri; X Han; D Nordström; J Hagström; K K Eklund
Journal:  Br J Dermatol       Date:  2017-03-22       Impact factor: 9.302

6.  Histamine H4 receptor in oral lichen planus.

Authors:  A Salem; A Al-Samadi; V Stegajev; H Stark; R Häyrinen-Immonen; M Ainola; J Hietanen; Y T Konttinen
Journal:  Oral Dis       Date:  2014-10-08       Impact factor: 3.511

7.  Histamine synthesis and content in benign and malignant breast tumours. Its effects on other host tissues.

Authors:  M Garcia-Caballero; E Neugebauer; F Rodriguez; I Nuñez de Castro; C Vara-Thorbeck
Journal:  Surg Oncol       Date:  1994-06       Impact factor: 3.279

Review 8.  Histamine H4 receptor: insights into a potential therapeutic target in breast cancer.

Authors:  Diego J Martinel Lamas; Elena S Rivera; Vanina A Medina
Journal:  Front Biosci (Schol Ed)       Date:  2015-06-01

Review 9.  Histamine receptor subtypes: a century of rational drug design.

Authors:  Miriam Walter; Holger Stark
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

10.  Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway.

Authors:  Tai Wei; Xin Cong; Xiang-Ting Wang; Xiao-Jian Xu; Sai-Nan Min; Peng Ye; Xin Peng; Li-Ling Wu; Guang-Yan Yu
Journal:  Oncotarget       Date:  2017-01-24
View more
  4 in total

Review 1.  Histamine receptors and cancer pharmacology: an update.

Authors:  Noelia A Massari; Melisa B Nicoud; Vanina A Medina
Journal:  Br J Pharmacol       Date:  2018-12-13       Impact factor: 8.739

2.  Activation of histamine H4 receptor suppresses the proliferation and invasion of esophageal squamous cell carcinoma via both metabolism and non-metabolism signaling pathways.

Authors:  Gong-Hao He; Jia-Qi Ding; Xin Zhang; Wen-Mang Xu; Xiao-Qian Lin; Mei-Jin Huang; Ju Feng; Ping Wang; Wen-Ke Cai
Journal:  J Mol Med (Berl)       Date:  2018-07-29       Impact factor: 4.599

3.  Combined impacts of histamine receptor H1 gene polymorphisms and an environmental carcinogen on the susceptibility to and progression of oral squamous cell carcinoma.

Authors:  Yi-Fang Ding; Yung-Wei Lin; Wen-Kuan Chiu; Chiao-Wen Lin; Yi-Chieh Yang; Lun-Ching Chang; Jungshan Chang; Shun-Fa Yang; Ming-Hsien Chien
Journal:  Aging (Albany NY)       Date:  2022-05-19       Impact factor: 5.955

4.  Expression of Rab1A in bladder cancer and its clinical implications.

Authors:  Hongwei Su; Ting Li; Chen Li; Xin Liu; Haibin Ling; Xiangdong Li
Journal:  Exp Ther Med       Date:  2020-09-03       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.